SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-007444
Filing Date
2020-02-27
Accepted
2020-02-27 16:55:50
Documents
3
Effectiveness Date
2020-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 ntla-s8.htm S-8 109046
2 EX-5.1 ntla-ex51_6.htm EX-5.1 8237
3 EX-23.2 ntla-ex232_7.htm EX-23.2 3660
  Complete submission text file 0001564590-20-007444.txt   121962
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236714 | Film No.: 20663265
SIC: 2835 In Vitro & In Vivo Diagnostic Substances